AKT1 and cancer: Since CHI3L1 is induced on epithelial cells and macrophages during inflammatory conditions as well as inflammation-associated cancer states by activating several important signaling pathways, including AKT and β-catenin, thus methylxanthine derivatives have potential anti-inflammatory and anti-cancer effects through the inhibition of CHI3L1.